Alcon launches new enhanced Air Optix contact lenses in the UK and Ireland
HydraGlyde Moisture Matrix Technology added to attract and retain moisture on soft contact lenses to deliver longer-lasting surface wettability
Alcon, a division of Novartis, has launched its new, enhanced Air Optix plus HydraGlyde contact lenses in the UK and Ireland.
The new contact lenses are the latest, enhanced addition to the Air Optix portfolio of monthly replacement, silicone hydrogel contact lenses.
HydraGlyde has been added to Air Optix contact lenses to deliver longer-lasting surface wettability to keep the contact lenses continuously hydrated throughout the day, which helps to improve patients’ wearing experience.
HydraGlyde Moisture Matrix is Alcon’s proprietary moisture technology that is currently featured in its premium contact lens care solutions, Opti-free PureMoist and AOSept Plus with HydraGlyde.
The moisture technology is designed to attract and retain moisture on soft contact lenses, and is especially designed for silicone hydrogel contact lenses.
Head of research and development for Alcon’s Vision Care franchise, George Yao, said: “We know from patients that discomfort and dryness represent the main cause of dropout for contact lens wearers. HydraGlyde Technology promotes a unique hydrophilic barrier that helps lower friction to provide longer-lasting moisture.
“Adding this exclusive moisture technology to the Air Optix contact lens will provide eye care professionals with a new option for their contact lens wearers looking for consistent comfort.”
Additionally, Air Optix contact lenses are designed with SmartShield Technology to maintain wettability and resist lipid deposits throughout the full wearing cycle.
The result of the combination of SmartShield and HydraGlyde is a contact lens that creates an ultra-thin protective layer to help shield the contact lenses from irritating deposits and keep their surface moist throughout the day, according to Alcon.
The new contact lenses are available in expanded parameters to meet the clinical requirements of more patients: +6.00D to -10.00D in 0.25D steps, plus -10.50D to -12.00D and +6.50D to +8.00D in 0.50D steps.
For more information, visit the Alcon website.